Cutaneous vasculitis in breast cancer treated with chemotherapy
- 21 July 2008
- journal article
- case report
- Published by Elsevier BV in Clinical Immunology
- Vol. 129 (1), 3-9
- https://doi.org/10.1016/j.clim.2008.07.001
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Drug-induced vasculitisCurrent Opinion in Rheumatology, 2008
- Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinibAnnals Of Oncology, 2007
- Henoch–Schönlein purpura (HSP) during treatment with anastrozoleAnnals Of Oncology, 2006
- Anti-HER2 Antibody Trastuzumab Inhibits CDK2-Mediated NPAT and Histone H4 Expression via PI3K PathwayCell Cycle, 2006
- The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapiesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2005
- Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatmentAnnals Of The Rheumatic Diseases, 2005
- Pharmacological background of EGFR targetingAnnals of Oncology, 2004
- Cyclic Lymphocytic Vasculitis Associated with Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2004
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- The spectrum of cutaneous disease in leukemiasJournal of Cutaneous Pathology, 1993